Many Pleural Mesothelioma Patients May Be Missing Out on Life-Extending Treatments

Support for mesothelioma patients

Too many patients with malignant pleural mesothelioma are not getting the trimodality treatment protocol that could significantly change their outcomes. That is the finding of a newly-published study conducted at MD Anderson Cancer Center in Houston, Texas. Researchers reviewed the records of more than 20,000 patients in the National Cancer Database with a definitive diagnosis of pleural mesothelioma between 2004 and 2014. They discovered that, … Continue reading Many Pleural Mesothelioma Patients May Be Missing Out on Life-Extending Treatments »

Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery

Researchers at MD Anderson Cancer Center say they may have found a way to help predict which peritoneal mesothelioma patients are most likely to develop complications after cytoreductive surgery and intraperitoneal chemotherapy. Cytoreductive surgery to remove as much of a mesothelioma tumor as possible, followed by a rinse of heated chemotherapy drugs in the abdomen is known as CRS + HIPEC. It has become a … Continue reading Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery »

A New Approach to Reducing Mesothelioma Risk in Asbestos-Exposed People

The Japanese researchers who first suggested that removing iron from the body could help prevent malignant mesothelioma have come up with a way to make the process even easier and safer. In their original 2016 study, scientists at Nagoya University Graduate School of Medicine induced a pre-mesothelioma state in lab rats by injecting their abdomens with deadly crocidolite asbestos. As predicted, the rats exhibited all … Continue reading A New Approach to Reducing Mesothelioma Risk in Asbestos-Exposed People »

Immune System Changes Could Signal Mesothelioma Risk

The state of an asbestos-exposed person’s immune system might give doctors clues about how likely they are to develop malignant mesothelioma. It’s a fear for any person who has worked around asbestos – that one day they may develop the asbestos-linked cancer, mesothelioma. Pleural mesothelioma can take decades to develop, causes few symptoms at first, and is extremely hard to treat. Right now, there is … Continue reading Immune System Changes Could Signal Mesothelioma Risk »

Fish and Sunlight May Lower Mesothelioma Risk

Want to lower your risk for malignant mesothelioma and other common cancers? Get more sunlight, eat more fish, and consider Vitamin D supplements. That advice comes from Michael Holick, MD, PhD, a long-time expert in Vitamin D at Boston University and is supported by a growing body of new research. In an article in the Journal of Clinical & Translational Endocrinology, Dr. Holick discusses the … Continue reading Fish and Sunlight May Lower Mesothelioma Risk »

Improving Communication for Mesothelioma Patients and Providers

When it comes to communicating with malignant mesothelioma patients and their families, a longitudinal approach where patients are followed throughout their cancer journey may be most effective. That is the suggestion of a lung  cancer communication study newly published in the European Journal of Cancer Care. Researchers at the University of Heidelberg in Germany and the University of Utah Population Health Sciences Department conducted interviews … Continue reading Improving Communication for Mesothelioma Patients and Providers »

Pleural Catheters May Shorten Hospital Time for Mesothelioma Patients

Mesothelioma patients with a buildup of lung fluid may spend less time in the hospital if they are treated with an indwelling pleural catheter than if they undergo talc pleurodesis. An international team of researchers in Australia, New Zealand, Singapore and Hong Kong have just published the results of a two-year clinical trial of 146 pleural mesothelioma patients who were suffering from the symptoms of … Continue reading Pleural Catheters May Shorten Hospital Time for Mesothelioma Patients »

Prophylactic Radiotherapy May Prevent Spread of Pleural Mesothelioma

mesothelioma diagnosis

Irradiating the sites where mesothelioma treatments are performed as a way to prevent new tumors is “effective, well tolerated, simple, fast and cost effective”. According to French researchers this prophylactic radiotherapy has the potential to extend mesothelioma survival with few downsides. Malignant Mesothelioma Can Spread After Intervention A number of mesothelioma treatments involve the insertion of some kind of instrument into the tumor site. In … Continue reading Prophylactic Radiotherapy May Prevent Spread of Pleural Mesothelioma »

Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy

A new study is casting some doubt on the value of a protein called PD-L1 as a way to select mesothelioma patients for targeted immunotherapy. Several of the most promising new treatments for malignant mesothelioma, including pembrolizumab (Keytruda) and avelumab (Avastin), are designed to inhibit PD-L1, a protein cells used to evade detection by the immune system. PD-L1 inhibitors like Keytruda have become an important … Continue reading Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy »

High Dose Radiotherapy Improves Mesothelioma Survival in New Study

Treating malignant pleural mesothelioma patients with high doses of targeted radiotherapy after surgery or biopsy may significantly extend their lives. That’s the message from a multi-center mesothelioma study conducted in Italy and recently published in a French medical journal. Mesothelioma Treatment with Radiotherapy Scientists analyzed the cases of 36 malignant pleural mesothelioma patients diagnosed between 2009 and 2012. Nineteen of the patients were treated with … Continue reading High Dose Radiotherapy Improves Mesothelioma Survival in New Study »

Get your free copy of
“Surviving Mesothelioma” Today!